← Back to list
─── European Union
EU GDP: The Regulatory Model for Pharma Cold Chain
EU Good Distribution Practice (GDP) 2013 and its subsequent revisions form the world’s strictest pharmaceutical cold chain regulation, covering transportation, storage, warehousing and returns end-to-end.
欧盟·est. 2013·EU pharmaceutical cold chain regulation
Key strengths
- Continuous temperature monitoring and traceability are mandated by law
- Every temperature excursion requires documented root-cause analysis
- Serious penalties, including revocation of distribution licenses
Transferability to China
EU GDP’s "every excursion → root-cause analysis" mechanism is an important reference for China’s Vaccine Administration Law implementation rules.
Deep dive
背景
GDP 是欧盟药品法规体系的核心组成，2013 年版本首次明确了温度敏感药品的全流程监控要求。
与 GMP 的关系
GMP 管"生产"，GDP 管"流通"。两者形成闭环。